approval
saveHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approval
community read0 votes
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 29, 2025 · 432d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMay 20, 2025 · 502d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJun 12, 2024 · 844d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalApr 5, 2024 · 912d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalSep 8, 2023 · 1122d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalApr 14, 2023 · 1269d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalMar 20, 2023 · 1294d ago
- approvalHYRIMOZ (ADALIMUMAB-ADAZ) — FDA approvalJul 18, 2022 · 1539d ago
same company · ±60 days · 6
- approvalTRAVOPROST: TRAVATAN Z (TRAVOPROST) — FDA approvalOct 9, 2025
- approvaltriamcinolone acetonide Rising: TRIAMCINOLONE ACETONIDE — FDA approvalOct 8, 2025
- approvalANASTROZOLE: ANASTROZOLE — FDA approvalOct 24, 2025
- approvalDIFLUPREDNATE: DUREZOL (DIFLUPREDNATE) — FDA approvalOct 27, 2025
- approvalJUBBONTI: JUBBONTI (DENOSUMAB-BBDZ) — FDA approvalOct 29, 2025
- approvalnatalizumab biosimilar: TYRUKO (NATALIZUMAB-SZTN) — FDA approvalOct 30, 2025
comments(0)
5-min edit window · permanent after that